19 June 2013
Keywords: avicena, progress, pd-02, minocycline, drugmaker, reported, encouraging
Article | 20 March 2006
US drugmaker Avicena has reported encouraging results from a Phase II study designed to evaluate its proprietary drug candidate, PD-02, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 July 2006
© 2013 thepharmaletter.com